|





| 产地 | 美国 |
| 品牌 | Avanti |
| 货号 | |
| 保存条件 | |
| 保质期 | 个月 |
Avanti Bioactive Lipids5 生物活性脂类5
870853P | ST1326;(R)-3-(3-tetradecylureido)-4-(trimethylammonio)butanoate, CAS 250694-07-6 |
857393P | THI ;2-acetyl-4-tetrahydroxybutyl imidazole; 2-acetyl-4(5)-tetrahydroxybutyl imidazole; 2-ATHBI; 2-acetyl-5-tetrahydroxybutyl imidazole, CAS 94944-70-4 |
870625P | Trans-AzCA4 ;(E)-4-(4-[(4-butylphenyl)diazenyl]phenyl)-N-(3-hydroxy-4-methoxybenzyl)butanamide, powder |
800725P | N-P Tyrosine PA; N-palmitoyl-tyrosine phosphoric acid (ammonium salt), CAS 799268-45-4 |
857345P | VPC 01091;((1R,3S)-1-amino-3-(3-octylphenyl)cyclopentyl)methanol (hydrochloride salt), powder |
857368P | VPC 01211; ((1R,3S)-1-ammonio-3-(4-octylphenyl)cyclopentyl)methyl hydrogen phosphate, powder |
857341P | VPC 12249 (S); (S)-phosphoric acid mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylamino-propyl] ester (ammonium salt), CAS 799268-73-8 |
857360P | VPC 23019; (R)-phosphoric acid mono-[2-amino-2-(3-octyl-phenylcarbamoyl)-ethyl] ester, CAS 449173-19-7 |
857367P | VPC 23153 ; (R)-phosphoric acid mono-[2-amino-2-(6-octyl-1H-benzoimiazol-2-yl)-ethyl] ester, CAS 787582-98-3 |
857365P | VPC 24191; (S)-phosphoric acid mono-[2-amino-3-(4-octyl-phenylamino)-propyl] ester, CAS 799268-83-0 |
857353P | VPC 31143 ;(R) N-{(1R)-2-hydroxy-1-[(phosphonooxy)methyl]ethyl}(9Z)octadec-9-enamide (ammonium salt), CAS 799268-80-7 |
857350P | VPC 32179 (R); (R)-phosphoric acid mono-{2-octadec-9-enoylamino-3-[4-(pyridin-2-ylmethoxy)-phenyl]-propyl} ester (ammonium salt), CAS 799268-76-1 |
857340P | VPC 32183 (S);(S)-phosphoric acid mono-{2-octadec-9-enoylamino-3-[4-(pyridin-2-ylmethoxy)-phenyl]-propyl} ester (ammonium salt), CAS 799268-75-0 |
857346P | VPC 44116 ; (R)-(3-amino-4-((3-octylphenyl)amino)-4-oxobutyl)phosphonic acid, CAS 925978-30-9 |
857347P | VPC 51299;(R,E)-(3-palmitamido-4-(4-((4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methoxy)phenyl)but-1-en-1-yl)phosphonic acid, powder |
857370P | VU0155056 ; N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthamide, CAS 1130067-18-3 |
857372P | VU0285655-1;APV; N-{2-[4-oxo-1-phenyl-1,3,8-triazaspiro(4.5)decan-8-yl]ethyl}quinoline-3-carboxamide,CAS 1158347-73-9 |
857371P | VU0359595 ;EVJ; (1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide,CAS 1246303-14-9 |
857391P | W140 ;S1P1 Control Molecule ;(S)-3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid (TFA salt), CAS 909725-64-0 |
857390P | W146;S1P1 Antagonist; (R)-3-Amino-(3-hexylphenylamino)-4-oxobutylphosphonic acid (TFA salt), CAS 909725-62-8 |